USSTOCK.TODAY
Pre-Market
Log in Sign up

Edwards Lifesciences beats earnings and revenue estimates, improving performance for three consecutive quarters

Nasdaq +1 · ·by G4L

EW Edwards Lifesciences Corp
$105.80 -0.01%
View chart & analysis →
  1. 1Edwards Lifesciences Corp reported adjusted earnings per share of $0.80, exceeding the consensus adjusted earnings per share of $0.73.
  2. 2Edwards Lifesciences Corp revenue of $1.716 billion represented a 2.1% beat compared to the consensus for Edwards Lifesciences Corp revenue.
  3. 3Management stated that the tailwinds from expanding TAVR market share have largely ended.

So what's the key point?

Edwards Lifesciences Corp earned more money than experts expected. Revenue was 2.1% higher than anticipated, but the trend of expanding market share has mostly concluded.

Source Nasdaq +1 · View original ↗

Related 3-line summaries

Cardinal Health and Edwards Lifesciences shares rise on strong earnings Nasdaq +1 · Nov 6Nike Downgraded; Home Depot Coverage Initiated The Fly · Oct 6Banner Corporation to release Q2 earnings on July 23 GuruFocus.com +4 · Jul 24
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news